CraftHealth
A 3D printing platform for personalized medicines and supplements that combines multiple medications into a single daily pill with controlled release profiles.
- CEO / Founder
- Wei Jian Goh
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $1M
- Latest Round
- Series A
- Key Investors
- Valuence Ventures, Mistletoe, Jenny Chen
Technology & Products
Key Products
["CraftMake 3D Printer","CraftControl software"]
Technological Advantage
Integration of CraftMake 3D printer and CraftControl software enables customizable shapes, formulations, and release kinetics.
Differentiation
Value Proposition
Combines multiple medications into a single pill with controlled release profiles, enhancing patient compliance and improving treatment outcomes.
How They Differentiate
Focus on combining multiple medications into a single pill with controlled release, offering superior patient compliance.
Market & Competition
Target Customers
Healthcare providers, pharmacies, and patients requiring personalized medication regimens.
Industry Verticals
["Healthcare","Pharmaceuticals","Medical Research"]
Competitors
Aprecia Pharmaceuticals; FabRx
Growth & Milestones
Growth Metrics
Craft Health has secured a new round of funding and signed an MOU with GMP Healthcare Ltd from the UK to offer 3D printing platform services into the UK and Europe.
Major Milestones
["Development of CraftMake 3D printer","Spin-off from National University of Singapore","Collaboration with healthcare providers"]